10.3390/molecules20046794 22 DaiJ
Table 9: Results at Week 52 in a Trial Comparing TRESIBA to Insulin Glargine U-100 in Adult Patients with Type 2 Diabetes Mellitus on OAD(s)* *OAD: oral antidiabetic agent **The change from baseline to end of treatment visit in HbA1c was analyzed using ANOVA with treatment, region, sex, and anti-diabetic treatment at screening as fixed effects, and age and baseline HbA1c as covariates
Proper titration starting at a low dose and gradually increasing was associated with better tolerability (Jastreboff et al., 2023)
Read reference Metabolic Support GLP-1 receptor reference compound widely studied in incretin-related pathway literature
The suitable chemical agent used for induction can be selected from IPTG (isopropylthiogalactoside), SUBSTITUTE SHEETS (RULE 26) tryptophan, nalidexic acid, oxalinic acid, nitrogen or sugars analogs